Generate Biomedicines’ Research Collaboration Agreement with Amgen

Goodwin advised Generate Biomedicine on the deal.Generate Biomedicines announced its research collaboration agreement with Amgen (NASDAQ: AMGN) to discover and create protein therapeutics for five clinical targets…